CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 4 Open-market buy Chief Executive Officer bought 500 shares at $4.55 ($2,275)
- 4 Open-market buy Director bought 16,500 shares at $4.48 ($73,920)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chief Medical Officer bought 10,000 shares at $3.97 ($39,650)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at $4.37 ($13,110)
- 4 Open-market buy Chief Financial Officer bought 300 shares at $4.10 ($1,230)
- 4 Open-market buy Chief Operating Officer bought 300 shares at $4.19 ($1,257)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 7,500 shares at $3.33 ($24,975)
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Chief Executive Officer bought 4,000 shares at $3.17 ($12,680)
- DEFA14A Proxy Proxy Materials
Page 46 of 76 · 1,519 filings